| Literature DB >> 26404336 |
Erin C Peckham1, Michael E Scheurer2, Heather E Danysh3, Joseph Lubega4, Peter H Langlois5, Philip J Lupo6.
Abstract
There is warranted interest in assessing the association between residential radon exposure and the risk of childhood cancer. We sought to evaluate the association between residential radon exposure and the incidence of childhood lymphoma in Texas. The Texas Cancer Registry (n = 2147) provided case information for the period 1995-2011. Denominator data were obtained from the United States Census. Regional arithmetic mean radon concentrations were obtained from the Texas Indoor Radon Survey and linked to residence at diagnosis. Exposure was assessed categorically: ≤25th percentile (reference), >25th to ≤50th percentile, >50th to ≤75th percentile, and >75th percentile. Negative binomial regression generated adjusted incidence rate ratios (aIRR) and 95% confidence intervals (CI). We evaluated lymphoma overall and by subtype: Hodgkin (HL; n = 1248), Non-Hodgkin excluding Burkitt (non-BL NHL; n = 658), Burkitt (BL; n = 241), and Diffuse Large B-cell (DLBCL; n = 315). There was no evidence that residential radon exposure was positively associated with lymphoma overall, HL, or BL. Areas with radon concentrations >75th percentile had a marginal increase in DLBCL incidence (aIRR = 1.73, 95% CI: 1.03-2.91). In one of the largest studies of residential radon exposure and the incidence of childhood lymphoma, we found little evidence to suggest a positive or negative association; an observation consistent with previous studies.Entities:
Keywords: Texas Cancer Registry; childhood cancer; epidemiology; lymphoma; residential radon
Mesh:
Substances:
Year: 2015 PMID: 26404336 PMCID: PMC4626958 DOI: 10.3390/ijerph121012110
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Description of the thirteen study regions of the The Texas Indoor Radon Survey, 1991.
| Region Name | Region Number | Measurements for Analysis, |
|---|---|---|
| Southwest Texas | 1 | 208 |
| El Paso | 2 | 97 |
| Big Bend | 3 | 122 |
| West Texas Shales | 4 | 241 |
| North Texas | 5 | 348 |
| Dallas/Fort Worth | 6 | 172 |
| East Texas | 7 | 296 |
| Llano Uplift | 8 | 213 |
| Central Texas (Austin-San Antonio) | 9 | 237 |
| Tertiary Sands Crescent | 10 | 204 |
| Harris County (Houston) | 11 | 122 |
| Gulf Coast | 12 | 215 |
| Texas Panhandle | 13 | 258 |
Figure 1Quartile distribution of residential radon exposure from The Texas Indoor Radon Survey, 1991.
Demographic characteristics of lymphoma malignancy subtypes among children and adolescents <20 years of age diagnosed in Texas, 1995–2011.
| Characteristic | All Lymphomas ( | Hodgkin Lymphoma ( | NHL Excluding BL ( | Burkitt Lymphoma ( | Diffuse Large B-Cell Lymphoma ( | Total TX Population <20 Years Old * ( |
|---|---|---|---|---|---|---|
| Age of Diagnosis (years), | ||||||
| <5 | 197 (9.2) | 38 (3.0) | 110 (16.7) | 49 (20.3) | 49 (20.3) | 1,610,302 (24.7) |
| 5 to <10 | 316 (14.7) | 117 (9.4) | 123 (18.7) | 76 (31.5) | 76 (31.5) | 1,660,902 (25.5) |
| 10 to <15 | 534 (24.9) | 323 (25.9) | 148 (22.5) | 63 (26.1) | 63 (26.1) | 1,642,973 (25.2) |
| 15 to <20 | 1100 (51.2) | 770 (61.7) | 277 (42.1) | 53 (22.0) | 53 (22.0) | 1,609,455 (24.7) |
| Sex, | ||||||
| Male | 1314 (61.2) | 702 (56.3) | 404 (61.4) | 208 (86.3) | 208 (86.3) | 3,348,530 (51.3) |
| Female | 833 (38.8) | 546 (43.8) | 254 (38.6) | 33 (13.7) | 33 (13.7) | 3,175,102 (48.7) |
| Race/Ethnicity, | ||||||
| Non-Hispanic White | 1029 (47.9) | 590 (47.3) | 310 (47.1) | 129 (53.5) | 129 (53.5) | 2,790,778 (42.8) |
| Hispanic White | 787 (36.7) | 447 (35.8) | 261 (39.7) | 79 (32.8) | 79 (32.8) | 1,484,094 (22.7) |
| Non-Hispanic Black | 243 (11.3) | 158 (12.7) | 61 (9.3) | 24 (10.0) | 24 (10.0) | 820,640 (12.6) |
| Other † | 88 (4.1) | 53 (4.3) | 26 (4.0) | 9 (3.7) | 9 (3.7) | 1,428,120 (21.9) |
| County-level SES/Level of Urbanization †, | ||||||
| Urban, Higher SES | 1421 (66.2) | 818 (65.5) | 434 (66.0) | 169 (70.1) | 169 (70.1) | 4,326,761 (66.3) |
| Urban, Lower SES | 510 (23.8) | 296 (23.7) | 167 (25.4) | 47 (19.5) | 47 (19.5) | 1,520,114 (23.3) |
| Rural, Higher SES | 144 (6.7) | 86 (6.9) | 37 (5.6) | 21 (8.7) | 21 (8.7) | 425,312 (6.5) |
| Rural, Lower SES | 72 (3.4) | 48 (3.9) | 20 (3.0) | 4 (1.7) | 4 (1.7) | 251,445 (3.9) |
| Mean Residential Radon Concentration (Bq/m3) | 33.3 | 32.4 | 34.3 | 34.8 | 35.3 | ----- |
SES, Socioeconomic status; TX, Texas; * Source: 2000 U.S. Census, U.S. Census Bureau; ** “Other” Race/Ethnicity includes, those who reported being Asian, American Indian/Alaska Native, Hawaiian Island/Pacific Islander, Some other race alone, and Two or more races. † Lower SES defined as counties with greater than the median proportion of the population living under the Federal Poverty Level; Urban defined as those counties with greater than or equal to 50% of the population living in Census defined “Urban” county.
Distribution of residential radon exposure from The Texas Indoor Radon Survey, 1991.
| Indoor Radon Concentration (Becquerel per Cubic Meter; Bq/m3) | |
|---|---|
| Arithmetic mean | 45.97 * |
| Geometric mean (95% CI) | 37.75 (25.19–56.58) |
| Minimum | 9.25 |
| Maximum | 122.10 |
| Percentile | |
| 25th | 25.90 |
| 50th | 40.70 |
| 75th | 48.10 |
| 90th | 96.20 |
| 99th | 122.10 |
* Mean radon concentration levels as measured in Bq/m3 for each geologic region across Texas were the unit of analysis for exposure assessment.
Associations between indoor radon exposure and incidence rates of lymphoma malignancy subtypes among children and adolescents <20 years of age diagnosed in Texas, 1995–2011.
| Lymphoma Subtype | Cases ( | IR * | IRR * (95% CI) | aIRR * (95% CI) | |
|---|---|---|---|---|---|
| ≤25th percentile (reference) | 970 | 34.25 | 1.00 | 1.00 | 0.35 |
| >25th to ≤50th percentile | 711 | 30.92 | 0.88 (0.70–1.10) | 0.89 (0.79–1.00) | |
| >50th to ≤75th percentile | 373 | 33.38 | 0.98 (0.73–1.32) | 0.90 (0.77–1.04) | |
| >75th percentile | 93 | 33.88 | 0.93 (0.67–1.30) | 1.05 (0.83–1.32) | |
| ≤25th percentile (reference) | 583 | 20.59 | 1.00 | 1.00 | 0.20 |
| >25th to ≤50th percentile | 391 | 17.00 | 0.86 (0.64–1.15) | 0.83 (0.71–0.98) | |
| >50th to ≤75th percentile | 227 | 20.32 | 0.99 (0.68–1.45) | 0.94 (0.77–1.14) | |
| >75th percentile | 47 | 17.12 | 0.81 (0.51–1.26) | 0.87 (0.63–1.20) | |
| ≤25th percentile (reference) | 289 | 10.20 | 1.00 | 1.00 | 0.96 |
| >25th to ≤50th percentile | 231 | 10.04 | 0.96 (0.74–1.25) | 1.00 (0.82–1.21) | |
| >50th to ≤75th percentile | 103 | 9.22 | 0.92 (0.66–1.29) | 0.82 (0.64–1.05) | |
| >75th percentile | 35 | 12.75 | 1.26 (0.83–1.93) | 1.37 (0.95–1.97) | |
| ≤25th percentile (reference) | 98 | 3.46 | 1.00 | 1.00 | 0.54 |
| >25th to ≤50th percentile | 89 | 3.87 | 0.98 (0.65–1.48) | 1.01 (0.73–1.38) | |
| >50th to ≤75th percentile | 43 | 3.85 | 1.08 (0.64–1.80) | 1.04 (0.71–1.52) | |
| >75th percentile | 11 | 4.01 | 1.05 (0.52–2.14) | 1.33 (0.70–2.53) | |
| ≤25th percentile (reference) | 123 | 4.34 | 1.00 | 1.00 | 0.22 |
| >25th to ≤50th percentile | 119 | 5.17 | 1.11 (0.80–1.55) | 1.11 (0.85–1.44) | |
| >50th to ≤75th percentile | 56 | 5.01 | 1.11 (0.74–1.68) | 1.01 (0.73–1.39) | |
| >75th percentile | 17 | 6.19 | 1.42 (0.81–2.49) | 1.73 (1.03–2.91) |
CI, confidence interval; IR, incidence rate; IRR, incidence rate ratio; * Per 100,000 individuals; aIRR, adjusted for race/ethnicity, sex, category of age at diagnosis, and county-level SES/level of urbanization.